Positioned To Be A Leader In The Integrated Healthcare Space

Offering innovative healthcare that provides body and mind wellness for patients through its clinics with digital and telemedicine

Sponsored
Message: API Pharma Covid test recall

Hello, 

Thank you for your inquiry. I do believe Steve has touched on this topic in recent interviews;  The recall of the sample tests that were sent out are not at all related to KAI nor will they have any impact on the MDEL application. These are two seperate matters and the recall does not remove pharma from the application process. Receiving the MDEL licence will give us the ability to import, sell and distribute medial devices in Canada to Canadians. We are optimistic in the timing of this. 

Sincerely,
 
Tamara Mason 
Business Development & Communications 
Share
New Message
Please login to post a reply